scispace - formally typeset
J

James B. Wing

Researcher at Osaka University

Publications -  53
Citations -  5229

James B. Wing is an academic researcher from Osaka University. The author has contributed to research in topics: Immune system & FOXP3. The author has an hindex of 21, co-authored 42 publications receiving 3586 citations. Previous affiliations of James B. Wing include Kyoto University & University of Sheffield.

Papers
More filters
Journal ArticleDOI

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, +462 more
- 01 Oct 2019 - 
TL;DR: These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community providing the theory and key practical aspects offlow cytometry enabling immunologists to avoid the common errors that often undermine immunological data.
Journal ArticleDOI

Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.

Desirée Schubert, +40 more
- 01 Dec 2014 - 
TL;DR: Taking together, mutations in CTLA4 resulting inCTLA-4 haploinsufficiency or impaired ligand binding result in disrupted T and B cell homeostasis and a complex immune dysregulation syndrome.
Journal ArticleDOI

The microbiota regulates type 2 immunity through RORγt+ T cells

Caspar Ohnmacht, +22 more
- 28 Aug 2015 - 
TL;DR: It is reported that microbiota-induced Tregs express the nuclear hormone receptor RORγt and differentiate along a pathway that also leads to TH17 cells, and acts as a key factor in balancing immune responses at mucosal surfaces.
Journal ArticleDOI

Guidelines for the use of flow cytometry and cell sorting in immunological studies

Andrea Cossarizza, +246 more
- 01 Oct 2017 - 
TL;DR: A rapid search in PubMed shows that using "flow cytometry immunology" as a search term yields more than 68 000 articles, the first of which is not about lymphocytes as mentioned in this paper.
Journal ArticleDOI

Regulatory T Cells and Human Disease.

Shimon Sakaguchi, +6 more
- 04 Feb 2020 - 
TL;DR: This review discusses the current understanding of T Reg immunobiology in normal and disease states, with the perspective on the realization of Treg-targeting therapies in the clinic.